drugset / Trial / NCT00434590

Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

NCT00434590

Phase 4 Terminated 10 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelPrevention

Summary

The study will evaluate kidney graft function in maintenance renal transplant patients.

Timeline

Start
2007-03
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Sodium Unknown 1440 mg

Indications

No indication recorded.